Immunotherapy in Gastroesophageal Cancers: Current Progress Future Directions

EVENT DETAILS AND REGISTRATION

Date:May 10, 2016

Time: 12:00 PM - 01:00 PM (PT)

Location:Conference Room B

Event Is:

  1. Examine the current evidence for the use of immune checkpoint inhibitors in gastroesophageal cancers
  2. Discuss biologic rationale and candidate biomarkers that predict for benefit of immune checkpoint inhibitors in gastroesophageal cancer
  3. Outline trials, both ongoing and in development, evaluating immunotherapy approaches in gastroesophageal cancer

Presenters:Joseph Chao, MD Assistant Clinical Professor City of Hope

ADDITIONAL DETAILS:

Objectives:

  1. Examine the current evidence for the use of immune checkpoint inhibitors in gastroesophageal cancers
  2. Discuss biologic rationale and candidate biomarkers that predict for benefit of immune checkpoint inhibitors in gastroesophageal cancer
  3. Outline trials, both ongoing and in development, evaluating immunotherapy approaches in gastroesophageal cancer

Who should attend:

Physicians, advanced care practitioners, nurses, pharmacists and all other health care professionals interested in the subject matter

CME credits:1.0 AMA PRA Category 1 CreditTM

R.S.V.P.: First come, first serve

Contact:

CME Dept.